Document is current
Any future updates will be listed below
-
Authors
Song, Junmin
Cali Daylan, Ayse Ece
Chi, Kuan-Yu
Prem Anand, Dharshana
Chang, Yu
Chiang, Cho-Han
Cheng, Haiying
- License Information
-
More Information
Article History
Received: 20 June 2024
Accepted: 23 September 2024
First Online: 4 October 2024
Declarations:
:
: Dr. Haiying Cheng has consulting or advisory roles at Janssen and G1 Therapeutics and receives research funding from Roche/Genentech (inst) and AstraZeneca (inst). The other authors do not have any industry affiliations to disclose.
: None.
